UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-C
Report by Issuer of Securities Quoted on NASDAQ
Inter-Dealer Quotation System
FILED PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17
or 15d-17 THEREUNDER
GENERAL GENETICS CORPORATION
770 S. Post Oak Lane, Suite 690
Houston, TX 77056
Issuer's telephone number, including area code: 713-840-0230
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of five percent or more in the
number of shares outstanding.
1. Title of security: Common Stock $.001 par value per share
2. Number of shares outstanding before the change: 5,000,000
3. Number of shares outstanding after the change: 21,790,000
4. Effective date of change: Exchange in connection with acquisition
September 15, 1996; Reverse split September 25, 1996
5. Method of Change: 1 for 20 Reverse Stock Split and Exchange of
shares in connection with acquisition
Acquisition of Private Mortgage Bankers, Inc. ("PMB") and its
subsidiaries in which 406,260,000 pre-reverse plit shares of Issuer were
exchanged for 100% of the issued and outstanding share interests of PMB.
Thereafter, a 1 for 20 reverse stock split; no fractional shares issued.
II. CHANGE IN NAME OF ISSUER
1. Name prior to change: General Genetics Corporation
2. Name after change: Note Bankers of America, Inc.
3. Effective date of charter amendment changing name: September 25,
1996
4. Date of shareholder approval of change, if required: August 30,
1996
Date: November 7, 1996 /S/ E. Donald DeYoung
---------------------------
E. Donald DeYoung
President
